Back to Sources Press Releases

Companies around the world are working on better ways to manage diabetes. Universities and other research institutions are working on finding a cure for diabetes and its complications. We provide an outlet for press releases from these organizations, so that you can better understand what they're working on.

Recent Press Releases
  1. [New!] Senseonics Announces First Study Participant Implanted in the U.S. as Part of the PROMISE 180-Day Sensor Clinical Study and the Submission of Key PMA Supplements to the FDA to Advance Current 90-Day Product.
  2. [New!] Beta Bionics Announces Final Closing of Its $63 Million Series B Financing.
  3. [New!] Zealand Pharma completes equity investment in strategic partner Beta Bionics.
  4. [New!] Bigfoot Biomedical Announces Next Step for Connected Injection System. See also Bigfoot Biomedical Announces Partnership with Lilly.
  5. [New!] New Prediction Feature for Hypoglycemia Now Available in Sugar.IQ(TM) Personal Diabetes Assistant App, Developed by Medtronic and IBM Watson Health.
  6. [New!] Cecelia Health Partners with JCHR and the Helmsley Trust To Transform the Lives and Health Outcomes of People Living with Diabetes.
  7. [New!] Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems.
  8. Tidepool to Develop Tidepool Loop with New $6M Funding Commitment from Helmsley Charitable Trust and JDRF.
  9. Xeris Pharmaceuticals Releases Additional Phase 3 Clinical Trial Data on Its Ready-to-Use Liquid Glucagon Pen.
  10. Diabetes Technology Society announces that Insulet Corporation's Omnipod DASH™ System is the first insulin pump evaluated under the DTSec Cybersecurity Standard.
  11. JDRF, ADA and Helmsley Charitable Trust Announce Funding of Quantitative Analysis of Insulin Purchased from Pharmacies in the U.S.
  12. Tidepool intends to deliver Loop as a supported, FDA-regulated mobile app in the App Store.
  13. Beta Bionics Awarded Up to $2 Million NIH Small Business Innovation Research (SBIR) Grant.
  14. Tech Update: Medtronic Minimed 670G approved in Canada.
  15. Results from Two Phase 3 Studies Show Lilly's Ultra Rapid Lispro (URLi) Met Primary Efficacy Endpoint in People with Type 1 and Type 2 Diabetes. See also Ultra-rapid insulin improves postprandial glucose levels in type 1, type 2 diabetes.
  16. Health Canada approves TRESIBA® for children with Type 1 diabetes.
  17. Abbott′s FreeStyle® Libre 2, with Optional Real-Time Alarms, Secures CE Mark for Use in Europe.
  18. Beyond Type 1 Receives $300,985 Helmsley Charitable Trust Grant for DKA Awareness Campaign.
  19. Diabetes Scholars - A Program of Beyond Type 1.
  20. Beta Bionics Secures an Initial $50 Million Series B Round.

[ Recent Press Releases | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 ]

To have your press release included on this page, send an e-mail to . Please be sure to include contact information in case we have questions. We reserve the right to include only those press releases that are consistent with our editorial positions.

  Back to Sources Return to the Top of This Page

Last Updated: Wednesday January 09, 2019 21:39:10
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.